We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Mobile Phone App Determines Risk of Preterm Birth

By HospiMedica International staff writers
Posted on 09 Mar 2020
A user-friendly mobile phone application will allow doctors to quickly calculate a woman's individual risk of preterm birth, claims a new study. More...


Developed by researchers at King’s College London (KCL; United Kingdom), QUiPP v2 calculates spontaneous preterm birth (sPTB) risk based on a woman's individual risk factors, such as previous preterm birth, late miscarriage, or symptoms, along with clinical test results that help to predict preterm birth, such as cervical length (CL), quantitative fetal fibronectin (qfFN) or both tests combined, and taking into account further risk factors, such as multiple pregnancy. The app then produces a simple individual percentage risk score.

To test the app, the researchers conducted a prospective secondary analysis of data of asymptomatic women at high risk of sPTB recruited in 13 UK preterm birth clinics. In all, 1,803 women (3,878 visits) were included in the training set, and 904 women (1,400 visits) in the validation set. The results revealed that QUiPP v2 showed high accuracy for the prediction of sPTB at < 30, < 34 and < 37 weeks' gestation, and within one, two, and four weeks of testing. The study was published in the March 2020 issue of Ultrasound in Obstetrics and Gynecology.

“We are delighted to be able to share the findings of our work, which shows that the QUiPP app is very reliable in predicting preterm birth in women at risk,” said lead author Jenny Carter, MD, of the KCL department of Women & Children's Health. “This should mean that women who need treatments are offered them appropriately, and also that doctors and women can be reassured when these treatments are not needed, which reduces the possibility of negative effects and unnecessary costs for the NHS.”

Preterm birth refers to the birth of a baby of less than 37 weeks gestational age, before the developing organs are mature enough to allow normal postnatal survival. The cause for preterm birth is in many situations elusive and unknown; many factors appear to be associated with the development of preterm birth, making the reduction of preterm birth a challenging proposition. Premature infants are at greater risk for short and long term complications, including disabilities and impediments in growth and mental development. Preterm birth is the major cause of neonatal mortality in developed countries.

Related Links:
King’s College London


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.